Works matching IS 09395555 AND DT 2021 AND VI 100 AND IP 11

Results: 32
    1
    2
    3
    4
    5
    6
    7
    8

    Impact of rituximab on COVID-19 outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2805, doi. 10.1007/s00277-021-04662-1
    By:
    • Levavi, Hannah;
    • Lancman, Guido;
    • Gabrilove, Janice
    Publication type:
    Article
    9

    Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2799, doi. 10.1007/s00277-021-04656-z
    By:
    • Arcani, Robin;
    • Colle, Julien;
    • Cauchois, Raphaël;
    • Koubi, Marie;
    • Jarrot, Pierre-André;
    • Jean, Rodolphe;
    • Boyer, Arthur;
    • Lachamp, Julie;
    • Tichadou, Antoine;
    • Couderc, Anne-Laure;
    • Farnault, Laure;
    • Costello, Regis;
    • Venton, Geoffroy;
    • Kaplanski, Gilles
    Publication type:
    Article
    10

    Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes: EBV and CMV reactivation post allo-HCT in NHL.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2773, doi. 10.1007/s00277-021-04642-5
    By:
    • Ding, Yiyang;
    • Ru, Yuhua;
    • Song, Tiemei;
    • Guo, Lingchuan;
    • Zhang, Xiang;
    • Zhu, Jinjin;
    • Li, Caixia;
    • Jin, Zhengming;
    • Huang, Haiwen;
    • Tu, Yuqing;
    • Xu, Mimi;
    • Xu, Yang;
    • Chen, Jia;
    • Wu, Depei
    Publication type:
    Article
    11

    Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2787, doi. 10.1007/s00277-021-04640-7
    By:
    • Gournay, Viviane;
    • Dumas, Guillaume;
    • Lavillegrand, Jean-Rémi;
    • Hariri, Geoffroy;
    • Urbina, Tomas;
    • Baudel, Jean-Luc;
    • Ait-Oufella, Hafid;
    • Maury, Eric;
    • Brissot, Eolia;
    • Legrand, Ollivier;
    • Malard, Florent;
    • Mohty, Mohamad;
    • Guidet, Bertrand;
    • Duléry, Rémy;
    • Bigé, Naïke
    Publication type:
    Article
    12
    13

    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2669, doi. 10.1007/s00277-021-04636-3
    By:
    • Chenou, Francine;
    • Hounkpe, Bidossessi Wilfried;
    • Domingos, Igor de Farias;
    • Tonassé, Wouitchékpo Vincent;
    • Batista, Thais Helena Chaves;
    • Santana, Rodrigo Marcionilo;
    • Arcanjo, Gabriela da Silva;
    • Alagbe, Adekunle Emmanuel;
    • Araújo, Aderson da Silva;
    • Lucena-Araújo, Antonio Roberto;
    • Bezerra, Marcos Andre Cavalcanti;
    • Costa, Fernando Ferreira;
    • Sonati, Maria de Fátima;
    • De Paula, Erich Vinicius;
    • dos Santos, Magnun Nueldo Nunes
    Publication type:
    Article
    14
    15
    16
    17

    Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

    Published in:
    2021
    By:
    • Heinicke, Thomas;
    • Krahl, Rainer;
    • Kahl, Christoph;
    • Cross, Michael;
    • Scholl, Sebastian;
    • Wolf, Hans‑Heinrich;
    • Hähling, Detlev;
    • Hegenbart, Ute;
    • Peter, Norma;
    • Schulze, Antje;
    • Florschütz, Axel;
    • Schmidt, Volker;
    • Reifenrath, Kolja;
    • Zojer, Niklas;
    • Junghanss, Christian;
    • Sayer, Herbert G.;
    • Maschmeyer, Georg;
    • Späth, Christian;
    • Hochhaus, Andreas;
    • Fischer, Thomas
    Publication type:
    Correction Notice
    18
    19
    20
    21
    22

    Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2763, doi. 10.1007/s00277-021-04607-8
    By:
    • Tachibana, Takayoshi;
    • Kanda, Junya;
    • Ishizaki, Takuma;
    • Najima, Yuho;
    • Tanaka, Masatsugu;
    • Doki, Noriko;
    • Fujiwara, Shin-ichiro;
    • Kimura, Shun-ichi;
    • Onizuka, Makoto;
    • Takahashi, Satoshi;
    • Saito, Takeshi;
    • Mori, Takehiko;
    • Fujisawa, Shin;
    • Sakaida, Emiko;
    • Miyazaki, Takuya;
    • Aotsuka, Nobuyuki;
    • Gotoh, Moritaka;
    • Watanabe, Reiko;
    • Shono, Katsuhiro;
    • Kanamori, Heiwa
    Publication type:
    Article
    23

    Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2689, doi. 10.1007/s00277-021-04624-7
    By:
    • Kulagin, Alexander D.;
    • Ptushkin, Vadim V.;
    • Lukina, Elena A.;
    • Davydkin, Igor L.;
    • Korobkin, Alexander V.;
    • Shamrai, Vladimir S.;
    • Konstantinova, Tatyana S.;
    • Kaporskaya, Tatyana S.;
    • Mitina, Tatyana A.;
    • Ksenzova, Tatyana I.;
    • Zuev, Evgeny V.;
    • Markova, Oksana A.;
    • Gapchenko, Elena V.;
    • Kudlay, Dmitry A.
    Publication type:
    Article
    24

    Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2813, doi. 10.1007/s00277-021-04622-9
    By:
    • Guery, Romain;
    • Suarez, Felipe;
    • Lanternier, Fanny;
    • Bougnoux, Marie Elisabeth;
    • Lecuyer, Hervé;
    • Avettand-Fenoel, Véronique;
    • Sibon, David;
    • Frenzel, Laurent;
    • Raphalen, Jean-Herlé;
    • Helias, Philippe;
    • Renaudier, Philippe;
    • Santa, Florin;
    • Lecuit, Marc;
    • Lortholary, Olivier;
    • Hermine, Olivier;
    • Aguilar, Claire;
    • Marçais, Ambroise
    Publication type:
    Article
    25
    26
    27

    Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2745, doi. 10.1007/s00277-021-04592-y
    By:
    • Nakazato, Tomonori;
    • Hagihara, Masao;
    • Sahara, Naohi;
    • Tamai, Yotaro;
    • Ishii, Ryuji;
    • Tamaki, Shigehisa;
    • Wake, Atsushi;
    • Tajika, Kenji;
    • Sakai, Rika;
    • Kobayashi, Takeshi;
    • Hua, Jian;
    • Inoue, Morihiro;
    • Aisa, Yoshinobu;
    • Fujisawa, Shin;
    • Miyazaki, Koji;
    • Irie, Seiji;
    • Tanaka, Eri;
    • Higashihara, Masaaki
    Publication type:
    Article
    28
    29
    30
    31
    32